Although studies show new neurons generated from progenitor cells in a healthy adult neocortex, neurogenic potential derived from stem/progenitor cells in the cortex of Alzheimer's patients still remains unsolved. In this study, we isolated the glial progenitor cells (GPCs) from the cortex of healthy (HC) and Alzheimer's disease (AD). The AD-GPCs displayed reduced capability to renew and decreased production of new neurons. Interestingly, we found significant reduction of [beta]-catenin in AD-GPCs compared to HC while glycogen synthase kinase 3[beta] (GSK-3[beta]) was promoted. Moreover, we found both increased phosphorylation of [beta]-catenin in AD-GPCs and their progeny cells. Amyloid [beta] peptide (A[beta]) treatment results in increase of GSK-3[beta] and a reduction of [beta]-catenin, ultimately impairment of neurogenesis of GPCs. Similar results were observed in GPCs from AD transgenic mice. These results suggest that decreased [beta]-catenin signaling by A[beta] may be one of causes for the lack of neurogenesis in AD-GPCs.
Interruption of [beta]-Catenin Signaling Reduces Neurogenesis in Alzheimer's Disease Brains
P. He,M. Staufenbiel,Yong Shen
Published 2008 in Nature Precedings
ABSTRACT
PUBLICATION RECORD
- Publication year
2008
- Venue
Nature Precedings
- Publication date
2008-09-05
- Fields of study
Biology, Medicine, Chemistry
- Identifiers
- External record
- Source metadata
Semantic Scholar
CITATION MAP
EXTRACTION MAP
CLAIMS
- No claims are published for this paper.
CONCEPTS
- No concepts are published for this paper.
REFERENCES
Showing 1-59 of 59 references · Page 1 of 1
CITED BY
Showing 1-46 of 46 citing papers · Page 1 of 1